GLOBAL HUMAN GROWTH HORMONE MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024
- Id : RNR-264674
- Category : Pharma Healthcare
- Publish Date : Feb-20
- Publisher : Research-N-Reports
- Pages : 123
- Format : PDF
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland. Scope of the Report: For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry. The downstream industries of Human Growth Hormone products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of Human Growth Hormone will be obvious. The worldwide market for Human Growth Hormone is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Human Growth Hormone in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers - Novo Nordisk - Pfizer - Eli Lilly - Merck Serono - F. Hoffmann-La Roche - Ferring Pharmaceuticals - GeneScience Pharmaceuticals - Ipsen - LG Life Sciences - Sandoz International - Anhui Anke Biotechnology Market Segment by Regions, regional analysis covers - North America (United States, Canada and Mexico) - Europe (Germany, France, UK, Russia and Italy) - Asia-Pacific (China, Japan, Korea, India and Southeast Asia) - South America (Brazil, Argentina, Colombia etc.) - Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers - Powder - Solvent Market Segment by Applications, can be divided into - Growth Hormone Deficiency (GHD) - Turner Syndrome - Chronic Renal Insufficiency - Prader Willi Syndrome - Small for Gestational Age - SHOX Deficiency - Others The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Human Growth Hormone product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Human Growth Hormone, with price, sales, revenue and global market share of Human Growth Hormone in 2017 and 2018. Chapter 3, the Human Growth Hormone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Human Growth Hormone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Human Growth Hormone market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Human Growth Hormone sales channel, distributors, customers, research findings and conclusion, appendix and data source.